Class information for:
Level 1: AMISULPRIDE//ANTIPSYCHOTICS//CLOZAPINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1348 2704 42.2 70%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
110 3       PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER 71389
617 2             ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA 13940
1348 1                   AMISULPRIDE//ANTIPSYCHOTICS//CLOZAPINE 2704

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMISULPRIDE authKW 419406 4% 36% 102
2 ANTIPSYCHOTICS authKW 385556 15% 8% 403
3 CLOZAPINE authKW 356285 11% 11% 289
4 RISPERIDONE authKW 307664 8% 12% 226
5 SCHIZOPHRENIA authKW 299349 35% 3% 955
6 TREATMENT RESISTANT SCHIZOPHRENIA authKW 231919 2% 48% 43
7 POLYPHARMACY authKW 200102 5% 13% 134
8 ATYPICAL ANTIPSYCHOTICS authKW 197956 6% 12% 152
9 OLANZAPINE authKW 180910 6% 9% 175
10 ANTIPSYCHOTIC POLYPHARMACY authKW 171736 1% 89% 17

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Psychiatry 130237 78% 1% 2109
2 Pharmacology & Pharmacy 8072 33% 0% 891
3 Psychology, Clinical 3351 8% 0% 224
4 Health Policy & Services 2942 6% 0% 153
5 Clinical Neurology 2569 15% 0% 396
6 Neurosciences 1156 14% 0% 386
7 Health Care Sciences & Services 413 3% 0% 83
8 Public, Environmental & Occupational Health 316 6% 0% 157
9 Psychology 271 3% 0% 72
10 Medicine, General & Internal 270 6% 0% 171

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TUNKU ABDUL RAHMAN NEUROSCI 79494 0% 54% 13
2 VET ADM C ITOL HEALTHCARE NETWORK VISN 5 67745 0% 100% 6
3 PSYCHIAT 42587 32% 0% 869
4 IBBTEC UC CSIC SODERCAN 36129 0% 80% 4
5 ABT PSYCHIAT NEUROL 22582 0% 100% 2
6 BROADMOOR HIGH SECURE HOSP 22582 0% 100% 2
7 BUR EVIDENCE BASED MED CLIN GUIDELINES 22582 0% 100% 2
8 HLTHCARE ORG IMPLEMENTAT 22582 0% 100% 2
9 IZOPHRENIA PROGRAM PROJESQ 22582 0% 100% 2
10 KESKINEN TERVEYSKESKUS 22582 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF CLINICAL PSYCHIATRY 68876 8% 3% 208
2 INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 38292 3% 4% 79
3 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 36769 3% 3% 94
4 PSYCHOPHARMAKOTHERAPIE 31032 1% 7% 37
5 INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 28107 2% 6% 45
6 PHARMACOPSYCHIATRY 22988 2% 3% 64
7 SCHIZOPHRENIA BULLETIN 21104 3% 3% 73
8 PSYCHIATRIC SERVICES 17611 3% 2% 80
9 SCHIZOPHRENIA RESEARCH 15895 3% 2% 91
10 ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE 12674 2% 2% 51

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 AMISULPRIDE 419406 4% 36% 102 Search AMISULPRIDE Search AMISULPRIDE
2 ANTIPSYCHOTICS 385556 15% 8% 403 Search ANTIPSYCHOTICS Search ANTIPSYCHOTICS
3 CLOZAPINE 356285 11% 11% 289 Search CLOZAPINE Search CLOZAPINE
4 RISPERIDONE 307664 8% 12% 226 Search RISPERIDONE Search RISPERIDONE
5 SCHIZOPHRENIA 299349 35% 3% 955 Search SCHIZOPHRENIA Search SCHIZOPHRENIA
6 TREATMENT RESISTANT SCHIZOPHRENIA 231919 2% 48% 43 Search TREATMENT+RESISTANT+SCHIZOPHRENIA Search TREATMENT+RESISTANT+SCHIZOPHRENIA
7 POLYPHARMACY 200102 5% 13% 134 Search POLYPHARMACY Search POLYPHARMACY
8 ATYPICAL ANTIPSYCHOTICS 197956 6% 12% 152 Search ATYPICAL+ANTIPSYCHOTICS Search ATYPICAL+ANTIPSYCHOTICS
9 OLANZAPINE 180910 6% 9% 175 Search OLANZAPINE Search OLANZAPINE
10 ANTIPSYCHOTIC POLYPHARMACY 171736 1% 89% 17 Search ANTIPSYCHOTIC+POLYPHARMACY Search ANTIPSYCHOTIC+POLYPHARMACY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 HASAN, A , FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , THIBAUT, F , MOLLER, HJ , (2012) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 1: UPDATE 2012 ON THE ACUTE TREATMENT OF SCHIZOPHRENIA AND THE MANAGEMENT OF TREATMENT RESISTANCE.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 13. ISSUE 5. P. 318 -378 246 49% 86
2 GALLEGO, JA , BONETTI, J , ZHANG, JP , KANE, JM , CORRELL, CU , (2012) PREVALENCE AND CORRELATES OF ANTIPSYCHOTIC POLYPHARMACY: A SYSTEMATIC REVIEW AND META-REGRESSION OF GLOBAL AND REGIONAL TRENDS FROM THE 1970S TO 2009.SCHIZOPHRENIA RESEARCH. VOL. 138. ISSUE 1. P. 18-28 118 83% 50
3 CORRELL, CU , GALLEGO, JA , (2012) ANTIPSYCHOTIC POLYPHARMACY A COMPREHENSIVE EVALUATION OF RELEVANT CORRELATES OF A LONG-STANDING CLINICAL PRACTICE.PSYCHIATRIC CLINICS OF NORTH AMERICA. VOL. 35. ISSUE 3. P. 661 -+ 98 87% 24
4 DAVIS, JM , CHEN, N , GLICK, ID , (2003) A META-ANALYSIS OF THE EFFICACY OF SECOND-GENERATION ANTIPSYCHOTICS.ARCHIVES OF GENERAL PSYCHIATRY. VOL. 60. ISSUE 6. P. 553-564 89 74% 606
5 BARNES, TRE , PATON, C , (2011) ANTIPSYCHOTIC POLYPHARMACY IN SCHIZOPHRENIA BENEFITS AND RISKS.CNS DRUGS. VOL. 25. ISSUE 5. P. 383 -399 84 75% 48
6 SAMARA, MT , DOLD, M , GIANATSI, M , NIKOLAKOPOULOU, A , HELFER, B , SALANTI, G , LEUCHT, S , (2016) EFFICACY, ACCEPTABILITY, AND TOLERABILITY OF ANTIPSYCHOTICS IN TREATMENT-RESISTANT SCHIZOPHRENIA A NETWORK META-ANALYSIS.JAMA PSYCHIATRY. VOL. 73. ISSUE 3. P. 199 -210 59 67% 10
7 BARNES, TRE , (2011) EVIDENCE-BASED GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: RECOMMENDATIONS FROM THE BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 25. ISSUE 5. P. 567 -620 163 27% 109
8 HONER, WG , PROCYSHYN, RM , CHEN, EYH , MACEWAN, GW , BARR, AM , (2009) A TRANSLATIONAL RESEARCH APPROACH TO POOR TREATMENT RESPONSE IN PATIENTS WITH SCHIZOPHRENIA: CLOZAPINE-ANTIPSYCHOTIC POLYPHARMACY.JOURNAL OF PSYCHIATRY & NEUROSCIENCE. VOL. 34. ISSUE 6. P. 433 -442 80 72% 7
9 VAN BENNEKOM, MWHL , GIJSMAN, HJ , ZITMAN, FG , (2013) ANTIPSYCHOTIC POLYPHARMACY IN PSYCHOTIC DISORDERS: A CRITICAL REVIEW OF NEUROBIOLOGY, EFFICACY, TOLERABILITY AND COST EFFECTIVENESS.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 27. ISSUE 4. P. 327 -336 55 79% 20
10 FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , MOLLER, HJ , (2005) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) - GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 1: ACUTE TREATMENT OF SCHIZOPHRENIA.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 6. ISSUE 3. P. 132-191 144 32% 166

Classes with closest relation at Level 1


Rank Class id link
1 3230 PALIPERIDONE PALMITATE//LONG ACTING INJECTABLE//LONG ACTING INJECTION
2 20379 AGRANULOCYTOSIS//CLOZAPINE//CLOZAPINE INDUCED AGRANULOCYTOSIS
3 20744 ASENAPINE//ZIPRASIDONE//LURASIDONE
4 7609 9 HYDROXYRISPERIDONE//NORCLOZAPINE//CLOZAPINE
5 14377 COCHRANE IZOPHRENIA GRP//ACUTE AGITATION//SCHIZOPHRENIA DRUG THERAPY
6 12231 POSTPSYCHOTIC DEPRESSION//CALGARY DEPRESSION RATING SCALE//SCHIZOPHRENIA
7 10773 SCHIZOPHRENIA//SUBJECTIVE TOLERABILITY//PERSONAL AND SOCIAL PERFORMANCE SCALE
8 12327 ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE
9 31207 SUPERSENSITIVITY PSYCHOSIS//4 OXAZEPINE DERIVATIVES//CODED INACTIVE MEDICATION
10 8547 NEGATIVE SYMPTOMS//DEFICIT SYNDROME//PANSS

Go to start page